IA
AXDX

IFP Advisors’s Accelerate Diagnostics AXDX Stock Holding History

IFP Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7
Closed -$1K – 3430
2022
Q4 		$1K Sell
7
-20
-74% -$218 ﹤0.01% 4284
2022
Q3 		$5K Hold
27
– – ﹤0.01% 3996
2022
Q2 		$5K Hold
27
– – ﹤0.01% 3751
2022
Q1 		$5K Buy
27
+25
+1,250% +$712 ﹤0.01% 3751
2021
Q4 		$1K Buy
+2
New +$111 ﹤0.01% 2935
2019
Q4 		– Sell
-20
Closed -$4K – 2846
2019
Q3 		$4K Buy
+20
New +$3.87K ﹤0.01% 2403
2019
Q1 		$4K Buy
+20
New +$3.75K ﹤0.01% 1913
2017
Q4 		– Sell
-17
Closed -$4K – 3809
2017
Q3 		$4K Hold
17
– – ﹤0.01% 3479
2017
Q2 		$5K Buy
17
+10
+143% +$2.71K ﹤0.01% 3371
2017
Q1 		$2K Hold
7
– – ﹤0.01% 3621
2016
Q4 		$1K Buy
+7
New +$1.66K ﹤0.01% 3750
2016
Q2 		– Sell
-20
Closed -$4K – 3835
2016
Q1 		$4K Buy
+20
New +$2.82K ﹤0.01% 1913

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return

IFP Advisors's AXDX Position: Q1 2023 in Review

IFP Advisors sold out of Accelerate Diagnostics (AXDX) in Q1 2023, closing a stake of 7 shares — an estimated $1K sold.

IFP Advisors first reported a position in AXDX in Q1 2016 and held it in 12 quarters. The position peaked at $5K in Q3 2022. 67 funds tracked by Wall St. Rank hold AXDX as of Q1 2023.

  • IFP Advisors reported no remaining Accelerate Diagnostics position as of Q1 2023 after selling out during the quarter.
  • IFP Advisors sold 7 Accelerate Diagnostics shares in Q1 2023, an estimated $1K.
  • IFP Advisors first reported a position in Accelerate Diagnostics in Q1 2016 and held it in 12 quarters.
  • IFP Advisors's Accelerate Diagnostics position peaked at $5K in Q3 2022.
  • 67 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.